Cancer Therapy

Patent No. EP2100615 (titled "Cancer Therapy") was filed by Biotempus on Feb 14, 2003. The application was issued on Feb 10, 2016.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BRISTOL MYERS SQUIBBNov 9, 2016MEWBURN ELLIS

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

EP2100615

BIOTEMPUS
Application Number
EP09007539A
Filing Date
Feb 14, 2003
Status
Revoked
Sep 12, 2025
Publication Date
Feb 10, 2016